🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to investigate the efficacy and safety of an infusion of IO...
Status
Recruiting
Location
The Angeles Clinic and Research Institute
Start Date
2022-07-20
Trial ID
NCT05361174
Treatments Being Tested
This prospective, single-center pilot study is being performed to find out ...
Status
Not Yet Recruiting
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2026-10-01
Trial ID
NCT07700121
This clinical trial is a prospective, multicenter, open-label, randomized, ...
Status
Recruiting
Location
Mayo Clinic
Start Date
2025-01-14
Trial ID
NCT06743126
This phase I/II trial tests the safety and side effects of LN-144 (Lifileuc...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2022-07-01
Trial ID
NCT05176470
Treatments Being Tested
This phase II trial tests how well lifileucel, with reduce dose fludarabine...
Status
Completed
Location
University of Kansas Cancer Center
Start Date
2023-12-21
Trial ID
NCT06151847
The objective of this expanded access protocol is to provide access to Out ...
Status
Available
Location
Banner Health MD Anderson
Start Date
TBD
Trial ID
NCT05398640
Treatments Being Tested
This is a Phase 3, multicenter, open-label, randomized, parallel group, tre...
Status
Recruiting
Location
University of Alabama at Birmingham: The Kirklin Clinic
Start Date
2023-03-30
Trial ID
NCT05727904
Treatments Being Tested
This is a Phase 2, multicenter, open-label study of lifileucel (tumor-infil...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute
Start Date
2025-11-28
Trial ID
NCT07288203
Treatments Being Tested
This is an open label study evaluating lifileucel (LN-144) in patients with...
Status
Recruiting
Location
Memorial Sloan Kettering Westchester
Start Date
2022-11-01
Trial ID
NCT05607095
Treatments Being Tested
A Phase 1/2, open-label study of a modified interleukin-2 fusion protein (I...
Status
Recruiting
Location
SCRI Oncology Partners- Denver
Start Date
2025-03-11
Trial ID
NCT06940739
Treatments Being Tested